SELBYVILLE, Delaware, May 15, 2018 /PRNewswire/ --

Global Insulin Delivery Devices Market size is anticipated to surpass USD 19 billion by 2024; according to a new research report by Global Market Insights. Increasing prevalence of diabetes and adoption of insulin delivery devices are the major factors driving the insulin delivery devices market. Rapidly growing demand for needle free minimally invasive delivery system fuels market growth and should significant augment the overall industry expansion in foreseeable future.

     (Logo: https://mma.prnewswire.com/media/661916/GMI.jpg )

Rising diabetes diagnosis rate worldwide, especially in developing countries is generating demand for insulin and thereby delivery devices. Furthermore, insurance coverage and reimbursement by public sector organizations for diabetes management in number of countries will favour market growth.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/1649

Growing awareness about early disease detection along with increasing availability of delivery devices will positively impact insulin delivery devices industry growth over the forecast period. However, high cost of insulin and associated devices will continue to abstain patients from regular and optimum management of the disease, especially in resource poor regions.

Insulin pens' business segment dominated the market in 2017, valuing over USD 6.6 billion and is forecast to hold its position by 2024. Within the insulin pen business, reusable pens will growth with CAGR more than 6.5% during the forecast period.

Browse key industry insights spread across 140 pages with over 119 market data tables & 8 figures & charts from the report, "Insulin Delivery Devices Market Size By Product (Pumps {Tubed Pumps, Tubeless Pumps},Pens {Reusable, Disposable}, Pen Needles {Standard, Safety}, Syringes), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, China, Japan India, South Korea, Australia, Brazil, Mexico, South Africa, Saudi Arabia), Application Potential, Competitive Market Share & Forecast, 2018 - 2024" in detail along with the table of contents: 

https://www.gminsights.com/industry-analysis/insulin-delivery-devices-market

The demand for injection free minimally invasive systems will drive pumps' market growth over the forecast timeframe. Factors such as, ease of use, needleless insulin delivery and portability will result in rapid adoption of the same in coming 5-7 years. The insulin pumps market is forecast to grow with CAGR of over 7% during projection years.

UK insulin delivery devices market valued over USD 500 million in 2017 and is forecast to grow with a commanding CAGR during the projection years. Demand for insulin pens happens to be high across the nation; however, demand for pumps, which has been lesser popular devices, should rise significantly over the forecast timeframe.

India insulin devices market should witness 13.5% growth owing to high number of diabetic population being untapped and increasing incidences of the same. Improving healthcare system, growing disposable income and awareness will be some of the major factors driving market growth.

China insulin devices market will be the largest by the end of 2024, growing with a CAGR of over 13% from 2018-2024. With nearly USD 25 billion diabetes care expenditure, the country is targeting diabetes management better than any developing nation across the globe.

Some of the key industry players operating in global insulin delivery devices market are Eli Lilly, Sanofi, Novo Nordisk, Beckton and Dickenson, Roche, Medtronic, Insulet Corporation and Ypsomed. Specialized devices manufacturing companies such as Insulet Corporation focus on novel product development; innovation is their major stranger to gain market share. On the other hand, established bigger companies focus on geographical expansion, merger and acquisition to expand their foothold in the industry.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/1649

Browse Related Reports: 

• Antidiabetics Market Size 2017 - 2024 

Antidiabetics Market share was valued over USD 49.5 billion in 2016 and is expected to witness more than 10.5% CAGR from 2017 to 2024. Growing geriatric population along with escalating diabetes prevalence across the globe should drive the antidiabetics market trends.

https://www.gminsights.com/industry-analysis/antidiabetics-market

• Diabetic Retinopathy Market Size 2017 - 2024 

Diabetic Retinopathy Market share was valued around USD 7 billion in 2016 and is anticipated to witness growth of over 6.5% CAGR from 2017 to 2024. Rising number of baby boomers globally coupled with growing incidences of diabetes will act as primary drivers for diabetic retinopathy market.

https://www.gminsights.com/industry-analysis/diabetic-retinopathy-market-report

About Global Market Insights 

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: +1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

Web: https://www.gminsights.com

Blog: https://www.gminsights.com/blogs

Connect with us: Facebook | Google+ | LinkedIn | Twitter

SOURCE Global Market Insights, Inc.